Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/3/2025

Incentive Spirometry and Hypotension Risk

Mechanism and High-Risk Populations

  • Patients with pulmonary arterial hypertension are at high risk for hypotension during respiratory maneuvers due to the critical balance between systemic vascular resistance (SVR) and pulmonary vascular resistance (PVR), and deep inspiratory maneuvers can acutely decrease right ventricular preload and increase afterload, potentially triggering sudden and severe hypotension 1
  • In pulmonary hypertension, maintaining SVR greater than PVR is crucial; any intervention that disrupts this balance can cause cardiovascular collapse, and the loss of sympathetic drive during sustained deep breathing exercises can precipitate hypotension in these vulnerable patients 1
  • The sustained inspiratory effort required during incentive spirometry can transiently reduce venous return and cardiac output in hemodynamically unstable patients, including those requiring vasopressor support or with borderline blood pressure 1

Clinical Precautions

  • Patients with known pulmonary hypertension should be monitored carefully and considered for alternative respiratory therapies, and aggressive incentive spirometry targets should be avoided in these patients 1
  • When incentive spirometry is used in at-risk patients, continuous hemodynamic monitoring is warranted, including blood pressure measurement before, during, and after initial sessions, and patients should be instructed to stop immediately if they experience symptoms such as lightheadedness or dizziness 1
  • In ICU settings with pulmonary hypertension patients, arterial line monitoring may be appropriate before initiating respiratory therapy 1

Screening and Monitoring

  • Screening for risk factors such as pulmonary hypertension, right heart failure, baseline hypotension, and vasopressor requirement is crucial before initiating incentive spirometry, and high-risk patients should be considered for alternative therapies or monitored continuously 1

Contraindications and Precautions for Incentive Spirometry

Patient Selection and Contraindications

  • The American Thoracic Society implies that large bullae (>1/3 hemithorax) in COPD patients represent a significant contraindication to incentive spirometry, as the forced inspiratory maneuvers can theoretically rupture bullae, leading to pneumothorax 2
  • Patients with altered mental status or inability to follow instructions should not use incentive spirometry, as the device requires voluntary cooperation and adequate inspiratory effort, according to guidelines from the American College of Chest Physicians 3, 4
  • Active hemoptysis is a relative contraindication to incentive spirometry due to the risk of worsening bleeding with forced respiratory maneuvers, as suggested by the American College of Chest Physicians 5

Important Clinical Considerations

  • Adequate pain control must be achieved before incentive spirometry can be effective, particularly in patients with rib fractures, as stated by the American Pain Society 5
  • Incentive spirometry should never be used in isolation but rather as part of comprehensive pulmonary care, including early mobilization and deep breathing exercises, according to the American Association for Respiratory Care 5
  • The American College of Physicians notes that the physical performance of diagnostic spirometry has not been associated with adverse effects in screening populations, but incentive spirometry involves repetitive forced inspiratory maneuvers that differ from diagnostic spirometry and carry different risk profiles 6
  • The American Thoracic Society suggests that COPD patients with known bullous disease should be monitored carefully and considered for alternative respiratory therapies 2